Stocksigma LogoStocksigma Logo

Ishita Drugs Schedules Board Meeting to Approve Q2 Results

Ishita Drugs & Industries Ltd has scheduled a meeting of its Board of Directors on 3rd Nov'26 to consider, approve, and record the company's unaudited

Ishita Drugs Schedules Board Meeting to Approve Q2 Results

Ishita Drugs & Industries Ltd 路 Intimation 路 03 Nov 2026, 5:30 am

Ishita Drugs Schedules Board Meeting to Approve Q2 Results Ishita Drugs & Industries Ltd has scheduled a meeting of its Board of Directors on 3rd Nov'26 to consider, approve, and record the company's unaudited financial results for the quarter ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in company securities by designated persons remains closed from 1st Oct'26 until 48 hours following the formal announcement of the quarterly financial results.

Original exchange filing (PDF)

More announcements from Ishita Drugs & Industries Ltd

All Ishita Drugs & Industries Ltd announcements